
基本信息:
- 专利标题: NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL
- 申请号:US15892229 申请日:2018-02-08
- 公开(公告)号:US20180222898A1 公开(公告)日:2018-08-09
- 发明人: Meyyappan Muthuppalaniappan , Srikant Viswanadha , Gayatri S. Merikapudi , Swaroop K. Vakkalanka
- 申请人: Rhizen Pharmaceuticals SA
- 优先权: IN2439/CHE/2009 20091008; IN2636/CHE/2009 20091030; IN158/CHE/2010 20100125; IN1513/CHE/2010 20100602; IN1514/CHE/2010 20100602
- 主分类号: C07D417/10
- IPC分类号: C07D417/10 ; A61K31/415 ; A61K31/422 ; A61K31/427 ; A61K31/433 ; A61K31/4439 ; A61K31/455 ; A61K31/496 ; A61K31/506 ; A61K31/5377 ; A61K45/06 ; C07D207/327 ; C07D207/337 ; C07D231/12 ; C07D295/195 ; C07D401/04 ; C07D401/10 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D403/10 ; C07D403/12 ; C07D403/14 ; C07D413/10 ; C07D413/12 ; C07D413/14 ; C07D417/12 ; C07D417/14 ; C12N5/078
摘要:
Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.
公开/授权文献:
- US10246450B2 Modulators of calcium release-activated calcium channel 公开/授权日:2019-04-02
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07D | 杂环化合物 |
------C07D417/00 | 杂环化合物,含两个或更多个杂环、至少有1个环有氮原子和硫原子作为仅有的杂环原子,C07D415/00组不包含的 |
--------C07D417/02 | .含有两个杂环 |
----------C07D417/10 | ..被含芳环的碳链连接的 |